Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Ying‐Hwa Chen"'
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 22 (2024)
Background Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce cardiovascular events. However, the precise mechanisms beyond glycemic control are not fully understood. The objective of this study was to determine the role of PDGF (platelet‐d
Externí odkaz:
https://doaj.org/article/fc89b3d55e044d8ba91a27ca9d9de8c3
Autor:
Tsung‐Ying Tsai, Hsin‐Bang Leu, Pai‐Feng Hsu, Ya‐Ling Yang, Su‐Chan Chen, Shao‐Sung Huang, Wan Leong Chan, Shing‐Jong Lin, Jaw‐Wen Chen, Ju‐Pin Pan, Min‐Ji Charng, Ying‐Hwa Chen, Tao‐Cheng Wu, Tse‐Min Lu, Po‐Hsun Huang, Hao‐Min Cheng, Chin‐Chou Huang, Shih‐Hsien Sung, Yenn‐Jiang Lin, Cheng‐Hsueh Wu
Publikováno v:
The Journal of Clinical Hypertension, Vol 24, Iss 10, Pp 1327-1338 (2022)
Abstract Blood pressure variability (BPV) is independently associated with higher cardiovascular risks. However, whether BPV is associated with poor outcomes for coronary artery disease (CAD) patients after percutaneous coronary intervention (PCI) re
Externí odkaz:
https://doaj.org/article/b76e25c9e7d6447a98f0c240a19fd697
Autor:
Tsung-Ying Tsai, Pai-Feng Hsu, Cheng-Hsueh Wu, Ya-Ling Yang, Su-Chan Chen, Shao-Sung Huang, Wan Leong Chan, Shing-Jong Lin, Jaw-Wen Chen, Ju-Pin Pan, Min-Ji Charng, Ying-Hwa Chen, Tao-Cheng Wu, Tse-Min Lu, Po-Hsun Huang, Hao-Min Cheng, Chin-Chou Huang, Shih-Hsien Sung, Yenn-Jiang Lin, Hsin-Bang Leu
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Phosphate has been linked to higher cardiovascular (CV) risk. However, whether phosphate is associated with poor outcomes for patients with coronary artery disease (CAD) after percutaneous coronary interventions (PCIs) remained undetermined.
Externí odkaz:
https://doaj.org/article/9483aeee379b47a7bc52d2d774520f8b
Autor:
Ya‐Ling Yang, Su‐Chan Chen, Cheng‐Hsueh Wu, Shao‐Sung Huang, Wan Leong Chan, Shing‐Jong Lin, Chia‐Yu Chou, Jaw‐Wen Chen, Pan Ju‐Pin, Min‐Ji Charng, Ying‐Hwa Chen, Tao‐Cheng Wu, Tse‐Min Lu, Pai‐Feng Hsu, Po‐Hsun Huang, Hao‐Min Cheng, Chin‐Chou Huang, Shih‐Hsien Sung, Yenn‐Jiang Lin, Hsin‐Bang Leu
Publikováno v:
The Journal of Clinical Hypertension, Vol 23, Iss 8, Pp 1622-1630 (2021)
Abstract Hypertension is a frequent manifestation of chronic kidney disease but the ideal blood pressure (BP) target in patients with coronary artery disease (CAD) with end‐stage renal disease (ESRD) (eGFR
Externí odkaz:
https://doaj.org/article/a01a931017d24412bd9afd0c40e85530
Publikováno v:
ESC Heart Failure, Vol 8, Iss 4, Pp 3418-3421 (2021)
Abstract A 69‐year‐old male underwent concomitant left ventricular assist device (LVAD) implantation and aortic valve repair procedure for moderate aortic insufficiency (AI). Due to recurrence of symptomatic heart failure and post‐repair AI det
Externí odkaz:
https://doaj.org/article/30c56cedeea5433bbf596e24ff552a46
Publikováno v:
BMC Cardiovascular Disorders, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Evidence on association between body composition and outcomes of transcatheter aortic valve implantation (TAVI) is limited for Asian patients. This study investigated the prognostic role of body composition parameters in Taiwanese
Externí odkaz:
https://doaj.org/article/5821aba7b4d045b682c6dc63a94dc5dc
Publikováno v:
Antioxidants, Vol 10, Iss 9, p 1403 (2021)
Serum bilirubin levels, which are determined by a complex interplay of various enzymes, including heme oxygenase-1 (HO-1) and uridine diphosphate–glucuronosyl transferase (UGT1A1), may be protective against progression of cardiovascular disease (CV
Externí odkaz:
https://doaj.org/article/15fb2bde406f4a45ab01b31bfbb160e3
Autor:
Lung-An Hsu, Yung-Hsin Yeh, Chi-Tai Kuo, Ying-Hwa Chen, Gwo-Jyh Chang, Feng-Chun Tsai, Wei-Jan Chen
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e108773 (2014)
Atrial fibrillation (AF) is associated with increased oxidative stress. Emerging evidence suggests that heme oxygenase-1 (HO-1) is a potent antioxidant system against various oxidative stress-related diseases. The human HO-1 promoter has a GT-repeat
Externí odkaz:
https://doaj.org/article/eb7bd66a80f14df6a64799ebf4e25935
Autor:
Ying-Hwa Chen, 陳嬰華
92
Background Heme oxygenase is a rate-limiting enzyme in heme degradation, leading to the generation of free iron, biliverdin, and carbon monoxide (CO). Induction of heme oxygenase-1 (HO-1) is implicated in antioxidant defense mechanism and can
Background Heme oxygenase is a rate-limiting enzyme in heme degradation, leading to the generation of free iron, biliverdin, and carbon monoxide (CO). Induction of heme oxygenase-1 (HO-1) is implicated in antioxidant defense mechanism and can
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/86637783543252673217
Publikováno v:
Mastering Structural Heart Disease. :19-29
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1030261a30c0188fd5207ffae3092696
https://doi.org/10.1002/9781119807841.ch3
https://doi.org/10.1002/9781119807841.ch3